The MELAcare Study: A New Method for Surveillance of Melanoma Patients

Exclusion Criteria

• •Advanced melanoma, clinical stages IIB, IIC, III, or IV
• •Patients with high risk of a new primary melanoma (dysplastic nevus syndrome, or family history of melanoma)
• •History of melanoma skin cancer prior to the index diagnosis
• •Previous cancer, excluding non-melanoma skin cancer
• •Comorbidity that makes skin self-examination impossible (e.g. physical or mental disabilities, dementia or decreased cognitive function)
• •non-detection of sentinel node in IB and IIA patients